Per 1,000 mL Hydroxyethyl starch (130/0.4) 60 g, NaCl 9 g
Indications/Uses
Hypovolemia caused by acute blood loss. Elective surgery & trauma patients, patients undergoing open-heart surgery in association w/ cardiopulmonary bypass, where alternative infusion solutions are insufficient.
View Voluven overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity. Severe sepsis, critically ill patients. Conditions where vol overload is a potential problem especially in cases of pulmonary oedema & congestive cardiac failure. Pre-existing coagulation or bleeding disorders. Intracranial bleeding, severe hypernatraemia or hyperchloraemia. Severe liver disease & renal impairment. Patients w/ burns, scalds & receiving dialysis treatment.
Elective surgery & trauma patients. Anaphylactic reactions. Avoid use in patients w/ pre-existing renal dysfunction. Discontinue use at the 1st sign of clinically relevant renal injury & relevant coagulopathy. Continue monitoring of renal function in hospitalized patients for at least 90 days. Monitor coagulation status in patients undergoing open heart surgery in association w/ cardiopulmonary bypass & liver function. Avoid fluid overload; assess fluid status & rate of infusion regularly during treatment especially in patients w/ cardiac insufficiency. Ensure sufficient fluid is to be administered. Electrolyte abnormalities. Pregnancy & lactation.
Sign Out
